17-44667697-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001145080.3(MEIOC):āc.1786A>Cā(p.Lys596Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,613,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00059 ( 0 hom., cov: 32)
Exomes š: 0.000067 ( 0 hom. )
Consequence
MEIOC
NM_001145080.3 missense
NM_001145080.3 missense
Scores
17
Clinical Significance
Conservation
PhyloP100: 3.87
Genes affected
MEIOC (HGNC:26670): (meiosis specific with coiled-coil domain) Predicted to be involved in several processes, including gamete generation; germline cell cycle switching, mitotic to meiotic cell cycle; and mRNA stabilization. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.011734992).
BP6
Variant 17-44667697-A-C is Benign according to our data. Variant chr17-44667697-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 2225864.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEIOC | NM_001145080.3 | c.1786A>C | p.Lys596Gln | missense_variant | 5/8 | ENST00000409122.7 | NP_001138552.2 | |
MEIOC | XM_005257236.4 | c.1786A>C | p.Lys596Gln | missense_variant | 5/9 | XP_005257293.1 | ||
MEIOC | XM_047435802.1 | c.1786A>C | p.Lys596Gln | missense_variant | 5/6 | XP_047291758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEIOC | ENST00000409122.7 | c.1786A>C | p.Lys596Gln | missense_variant | 5/8 | 5 | NM_001145080.3 | ENSP00000386452 | P1 | |
MEIOC | ENST00000409464.1 | c.1288A>C | p.Lys430Gln | missense_variant | 2/3 | 2 | ENSP00000386586 |
Frequencies
GnomAD3 genomes AF: 0.000591 AC: 90AN: 152216Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
90
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000136 AC: 34AN: 249522Hom.: 0 AF XY: 0.0000815 AC XY: 11AN XY: 134944
GnomAD3 exomes
AF:
AC:
34
AN:
249522
Hom.:
AF XY:
AC XY:
11
AN XY:
134944
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000671 AC: 98AN: 1461208Hom.: 0 Cov.: 33 AF XY: 0.0000592 AC XY: 43AN XY: 726842
GnomAD4 exome
AF:
AC:
98
AN:
1461208
Hom.:
Cov.:
33
AF XY:
AC XY:
43
AN XY:
726842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000591 AC: 90AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000537 AC XY: 40AN XY: 74506
GnomAD4 genome
AF:
AC:
90
AN:
152334
Hom.:
Cov.:
32
AF XY:
AC XY:
40
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
10
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
20
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at